Assay ID | Title | Year | Journal | Article |
AID412493 | Antibacterial activity against wild type Escherichia coli at 30 nmol after 16 to 20 hrs | 2009 | Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
| Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines. |
AID1322286 | Drug uptake in Mycobacterium smegmatis ATCC 700084 at 100 uM by LC-MS/Ms analysis | 2016 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
| Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes. |
AID1322285 | Drug uptake in Escherichia coli ATCC 25922 at 100 uM by LC-MS/Ms analysis | 2016 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
| Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes. |
AID412491 | Antibacterial activity against Staphylococcus aureus ATCC 25923 at 30 nmol after 16 to 20 hrs | 2009 | Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
| Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines. |
AID408604 | Immunosuppressive activity against human PBMC assessed as inhibition of allogenic mixed lymphocyte reaction | 2008 | Journal of medicinal chemistry, May-22, Volume: 51, Issue:10
| Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. |
AID412494 | Antibacterial activity against Escherichia coli delta ABN mutant lacking peptidase A, B, N at 30 nmol after 16 to 20 hrs | 2009 | Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
| Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines. |
AID1322284 | Drug uptake in Bacillus subtilis ATCC 6051 at 100 uM by LC-MS/Ms analysis | 2016 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
| Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes. |
AID412492 | Antibacterial activity against Enterococcus faecalis ATCC 29212 at 30 nmol after 16 to 20 hrs | 2009 | Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
| Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines. |
AID408613 | Immunosuppressive activity against human PBMC assessed as inhibition of allogenic mixed lymphocyte reaction at 0.1 uM | 2008 | Journal of medicinal chemistry, May-22, Volume: 51, Issue:10
| Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. |
AID408606 | Immunosuppressive activity against human PBMC assessed as inhibition of allogenic mixed lymphocyte reaction at 0.5 uM | 2008 | Journal of medicinal chemistry, May-22, Volume: 51, Issue:10
| Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. |
AID1322282 | Inhibition of aminoacyl tRNA synthetase in T7 coupled rabbit reticulocyte lysate assessed as reduction in transcription/translation of luciferase template DNA propagated in Escherichia coli DH5alpha after 90 mins | 2016 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
| Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes. |
AID1322281 | Inhibition of recombinant Yersinia pestis C-terminal His6-tagged HMWP2 cysteine adenylation domain (1 to 1491 residues) expressed in Escherichia coli BL21(DE3) using 7-Methyl-6-thioguanosine as substrate preincubated for 10 mins followed by L-cysteine add | 2016 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
| Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes. |
AID1322283 | Inhibition of recombinant Yersinia pestis C-terminal His6-tagged HMWP2 cysteine adenylation domain (1 to 1491 residues) expressed in Escherichia coli BL21(DE3) after 15 mins in presence of L-cysteine by ATP-[32P]-pyrophosphate exchange assay | 2016 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
| Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |